PAXIS: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Phase 2 Study (Part 1) Followed by an Open-Label Period (Part 2) to Assess the Efficacy and Safety of Pacritinib in Patients with VEXAS Syndrome. - Beck, David B.; Heiblig, Maël; Savic, Sinisa; Ferrada, Marcela A.; Mekinian, Arsène; Chowdhury, Onima; Hammond, Danielle; Weeks, Lachelle D.; Gurnari, Carmelo; Kirino, Yohei; Georgin-Lavialle, Sophie; Buckley, Sarah A.; et al. (Journal of Clinical Medicine, 2026)